Accelerate Diagnostics
AXDX
#9648
Rank
A$45.59 M
Marketcap
$1.82
Share price
-4.17%
Change (1 day)
-73.02%
Change (1 year)

Accelerate Diagnostics (AXDX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$0.12 Billion

According to Accelerate Diagnostics's latest financial reports the company's total liabilities are A$0.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Accelerate Diagnostics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$0.12 B-21.28%
2021-12-31A$0.16 B-19.82%
2020-12-31A$0.20 B0.32%
2019-12-31A$0.20 B11.57%
2018-12-31A$0.18 B1981.79%
2017-12-31A$8.72 M24.82%
2016-12-31A$6.98 M-19.29%
2015-12-31A$8.65 M85.94%
2014-12-31A$4.65 M116.96%
2013-12-31A$2.14 M
2012-07-31A$2.26 M71.99%
2011-07-31A$1.31 M-12.49%
2010-07-31A$1.5 M-5.93%
2009-07-31A$1.59 M6.39%
2008-07-31A$1.5 M1.86%
2007-07-31A$1.47 M1.97%
2006-07-31A$1.44 M-17.96%
2005-07-31A$1.76 M24.88%
2004-07-31A$1.41 M-9.37%
2003-07-31A$1.55 M-33.72%
2002-07-31A$2.35 M6.19%
2001-07-31A$2.21 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$81.16 B 63,349.92%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.45 B 8,074.09%๐Ÿ‡บ๐Ÿ‡ธ USA
A$49.70 B 38,759.60%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.93 B 3,756.14%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.51 B 302.59%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.75 B 5,184.67%๐Ÿ‡บ๐Ÿ‡ธ USA